Echocardiographic Predictors of Long-Term Survival in Patients Undergoing Cardiac Resynchronization Therapy: What Is the Optimal Metric?

被引:17
|
作者
Rickard, John [1 ]
Baranowski, Bryan [1 ]
Tang, W. H. Wilson [1 ]
Grimm, Richard A. [1 ]
Niebauer, Mark [1 ]
Cantillion, Daniel [1 ]
Wilkoff, Bruce L. [1 ]
Varma, Niraj [1 ]
机构
[1] Cleveland Clin, Div Cardiol, Inst Heart & Vasc, 9500 Euclid Ave, Cleveland, OH 44195 USA
关键词
clinical: implantable devices--biventricular pacing; defibrillator; HEART-FAILURE; VOLUME; FRACTION;
D O I
10.1111/jce.13175
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reverse Remodeling Survival CRT BackgroundMultiple definitions of reverse ventricular remodeling (RVR) employing various changes in left ventricular end-systolic (LVESV) or diastolic volumes (LVEDVs) or left ventricular ejection fraction (LVEF) have been used in determining cardiac resynchronization therapy (CRT) response, making comparability across studies difficult. We compared different metrics to each other, and in combination, in terms of association with long-term outcomes. MethodsWe collected clinical and echocardiographic data on 436 patients undergoing CRT. LVEF was assessed via a combined volumetric and visual assessment. Volumes were manually traced. Using a nested multivariate model of a priori determined predictors of long-term survival free of left ventricular assist device (LVAD) or heart transplant, multiple definitions of RVR were added to the model individually to determine which provided the best model fit. ResultsOver a mean follow-up of 5.4 2.3 years, there were 198 endpoints (10 LVADs, 15 heart transplants, and 173 deaths). When added to a nested model controlling for multiple potential confounders, all definitions of RVR were significantly associated with improved survival. Changes in LVEF and LVESV were superior to changes in LVEDV. A combination metric of an LVEF improvement 5% and LVESV reduction 10% was the best overall metric for model fit. ConclusionsChanges in LVESV and LVEF are better predictors of long-term outcome following CRT compared to changes in LVEDV. Adding an assessment of LVEF to reduction in LVESV 10% provided the best overall definition for RVR in predicting CRT outcomes.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 50 条
  • [41] LONG-TERM SURVIVAL OF PATIENTS UNDERGOING CARDIAC ELECTROPHYSIOLOGIC STUDIES
    WYNN, J
    MIURA, D
    TORRES, V
    KEEFE, D
    BERCHIN, B
    FLOWERS, D
    SOMBERG, JC
    CLINICAL RESEARCH, 1986, 34 (02): : A356 - A356
  • [42] Long-Term Changes in Intracardiac Impedance in Cardiac Resynchronization Therapy Patients
    Gadler, Fredrik
    Holmstrom, Nils
    Hedberg, Sven-Erik
    Karlsson, Andreas
    Valzania, Cinzia
    Eriksson, Maria J.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : S68 - S68
  • [43] Trends of LVEF in patients with long-term treatment of cardiac resynchronization therapy
    Yang, Xinwei
    Hua, Wei
    Wang, Jing
    Liu, Zhimin
    Chen, Keping
    Zhang, Shu
    CARDIOLOGY, 2014, 129 : 100 - 100
  • [44] Long-term benefits of cardiac resynchronization therapy in heart failure patients
    Kostic, Tomislav
    Perisic, Zoran
    Milic, Dragan
    Mitov, Vladimir
    Koracevic, Goran
    Salinger-Martinovic, Sonja
    Apostolovic, Svetlana
    Zivkovic, Milan
    Stanojevic, Dragana
    Golubovic, Mladjan
    Markovic, Sasa
    HEALTHMED, 2012, 6 (12): : 4113 - 4119
  • [45] Clinical Long-Term Response to Cardiac Resynchronization Therapy Is Independent of Persisting Echocardiographic Markers of Dyssynchrony
    Naegeli, Barbara
    Brunner-La Rocca, Hans-Peter
    Jost, Christine Attenhofer
    Fah-Gunz, Anja
    Maurer, Dominik
    Bertel, Osmund
    Scharf, Christoph
    CARDIOLOGY RESEARCH, 2014, 5 (06) : 163 - 170
  • [46] Echocardiographic predictors of positive response to cardiac resynchronization therapy
    Rinkuniene, D.
    Bucyte, S.
    Laukaitiene, J.
    Jurkevicius, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 45 - 45
  • [47] Clinical and echocardiographic predictors of nonresponse to cardiac resynchronization therapy
    Shanks, Miriam
    Delgado, Victoria
    Ng, Arnold C. T.
    Auger, Dominique
    Mooyaart, Eline A. Q.
    Bertini, Matteo
    Marsan, Nina Ajmone
    van Bommel, Rutger J.
    Holman, Eduard R.
    Poldermans, Don
    Schalij, Martin J.
    Bax, Jeroen J.
    AMERICAN HEART JOURNAL, 2011, 161 (03) : 552 - 557
  • [48] Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy
    Auricchio, Angelo
    Metra, Marco
    Gasparini, Maurizio
    Lamp, Barbara
    Klersy, Catherine
    Curnis, Antonio
    Fantoni, Cecilia
    Gronda, Edoardo
    Vogt, Juergen
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (02): : 232 - 238
  • [49] Risk Stratification for Long-term Survival Benefit With Cardiac Resynchronization Therapy in Mild Heart Failure Patients
    Biton, Yitschak
    Goldenberg, Ilan
    Zareba, Wojciech
    Costa, Jason
    Mcnitt, Scott
    Polonsky, Bronislava
    Moss, Arthur J.
    Kutyifa, Valentina
    CIRCULATION, 2015, 132
  • [50] Cardiac Resynchronization Therapy: Long-Term Alternative to Cardiac Transplantation?
    Hansky, Bert
    Vogt, Juergen
    Zittermann, Armin
    Gueldner, Holger
    Heintze, Johannes
    Schulz, Uwe
    Horstkotte, Dieter
    Tenderich, Gero
    Koerfer, Reiner
    ANNALS OF THORACIC SURGERY, 2009, 87 (02): : 432 - 439